CClinicalTrials.gg
Status unknownNCT01384136Updated Jun 28, 2011

The Telomere System in Cord Blood and in the Placenta in High Risk Pregnancies

An observational study in Telomere Length, Mechanisms of Telomter Homeostasis and High Risk Pregnancies, sponsored by Meir Medical Center. Status unknown at 1 site in Israel. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-06-28.

Sponsored by Meir Medical Center · Observational

The sponsor has not verified this record recently (last verified Jun 2011), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The telomere system stabilizes the chromosomes. Telomeres are shortened during senescence, in cases of genetic instability and secondary to stress.

The investigators aim is to study the telomere system in cord blood and in the placenta immediately after the delivery in pregnancies defined as high risk pregnancies following sterss events such as placental insufficiency, preeclampsia, diabetes.

The investigators intend to compare the telomere system in maternal blood to cord blood and to placental biopsies and to study the influence of different stressogenes on this system.

02

Conditions studied

  • Telomere Length
  • Mechanisms of Telomter Homeostasis
  • High Risk Pregnancies
03

In context

Lead sponsor

Meir Medical Center is the lead sponsor of 389 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

High risk pregnancies, third trimester, after the delivery/

Inclusion criteria

  • Third trimester post delivery
  • Intrauterine growth restriction
  • Preeclampsia
  • Diabetes
  • Control - low risk normal pregnancies

Exclusion criteria

Exclusion Criteria:

  • Patients who do not want to participate
  • Known HIV or Hepatitis
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)

Groups and cohorts

  • High risk pregnancy
  • |Control - Normal low risk pregnancies
06

Study locations

1 site
  • Meir Medical Center
    Kfar Saba, Israel
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 28, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01384136
Lead sponsor
Meir Medical Center
First posted
Jun 28, 2011
Start date
Jun 2011
Primary completion
Jun 2015 (estimated)
Completion
Jun 2015 (estimated)
Last update
Jun 28, 2011

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion